Reply: Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies

J Am Coll Cardiol. 2013 Dec 24;62(25):2452. doi: 10.1016/j.jacc.2013.08.712. Epub 2013 Sep 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Carbazoles / administration & dosage*
  • Enalapril / administration & dosage*
  • Female
  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Male
  • Propanolamines / administration & dosage*
  • Ventricular Dysfunction, Left / drug therapy*
  • Ventricular Dysfunction, Left / prevention & control*

Substances

  • Antineoplastic Agents
  • Carbazoles
  • Propanolamines
  • Enalapril